Prasad Raju
Chief Financial Officer
Prasad Raju has filed 6 SEC Form 4 filings (18 transaction rows) across 1 company, with disclosures dating back to 2025. 6 of those filings fall inside the rolling window. Most recent filing: Aug 11, 2026.
On the most recent filing, Prasad Raju is listed as Chief Financial Officer at CRISPR Therapeutics AG. Inside the rolling window, Prasad Raju reported no open-market purchases and 5 open-market sales totaling $5.1M in CRSP. The largest disclosed transaction in the window is a sale of 34,972 CRSP shares on Jan 22, 2026, worth $2.1M.
Companies traded
Other insiders at CRSP
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$5.1M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Prasad Raju made?
Prasad Raju has filed 6 SEC Form 4 filings (18 transaction rows) across 1 company since 2025.
Which companies does Prasad Raju trade?
Prasad Raju has filed SEC Form 4 disclosures for 1 company, including CRSP.
When was Prasad Raju's most recent SEC Form 4 filing?
Prasad Raju's most recent SEC Form 4 filing on Tracefour is dated Aug 11, 2026.
What is Prasad Raju's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Prasad Raju is listed as Chief Financial Officer.
What is Prasad Raju's total buy and sell value in the current window?
Inside the rolling retention window, Prasad Raju bought $0 and sold $5.1M based on SEC Form 4 filings.
What was Prasad Raju's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 34,972 CRSP shares on 2026-01-22, worth $2.1M, per SEC Form 4 filings.